MAXIMUS, Inc. (NYSE:MMS) – Equities research analysts at First Analysis issued their Q3 2019 EPS estimates for MAXIMUS in a research note issued to investors on Sunday, February 10th. First Analysis analyst F. Sparacino anticipates that the health services provider will post earnings per share of $0.95 for the quarter. First Analysis also issued estimates for MAXIMUS’s FY2019 earnings at $3.75 EPS and FY2020 earnings at $4.25 EPS.
A number of other brokerages also recently issued reports on MMS. Zacks Investment Research upgraded shares of MAXIMUS from a “hold” rating to a “buy” rating and set a $78.00 price target on the stock in a report on Tuesday. ValuEngine upgraded shares of MAXIMUS from a “hold” rating to a “buy” rating in a report on Friday, November 30th.
Shares of NYSE MMS opened at $69.68 on Tuesday. The company has a debt-to-equity ratio of 0.11, a quick ratio of 2.32 and a current ratio of 2.32. The firm has a market capitalization of $4.46 billion, a price-to-earnings ratio of 20.49, a P/E/G ratio of 1.91 and a beta of 1.02. MAXIMUS has a 52-week low of $60.00 and a 52-week high of $72.45.
MAXIMUS (NYSE:MMS) last announced its quarterly earnings results on Thursday, February 7th. The health services provider reported $0.86 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.80 by $0.06. The company had revenue of $664.60 million for the quarter, compared to the consensus estimate of $672.08 million. MAXIMUS had a net margin of 8.94% and a return on equity of 20.09%. MAXIMUS’s revenue for the quarter was up 6.7% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.89 EPS.
The business also recently declared a quarterly dividend, which will be paid on Thursday, February 28th. Shareholders of record on Friday, February 15th will be issued a $0.25 dividend. The ex-dividend date is Thursday, February 14th. This represents a $1.00 dividend on an annualized basis and a yield of 1.44%. MAXIMUS’s dividend payout ratio is currently 29.41%.
In other MAXIMUS news, Director Russell A. Beliveau sold 1,000 shares of MAXIMUS stock in a transaction on Wednesday, January 2nd. The shares were sold at an average price of $64.14, for a total value of $64,140.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Mark Andrekovich sold 7,795 shares of MAXIMUS stock in a transaction on Friday, November 30th. The stock was sold at an average price of $70.42, for a total transaction of $548,923.90. Following the completion of the transaction, the insider now directly owns 19,272 shares of the company’s stock, valued at $1,357,134.24. The disclosure for this sale can be found here. Over the last quarter, insiders sold 67,902 shares of company stock worth $4,761,681. 2.20% of the stock is currently owned by insiders.
Large investors have recently modified their holdings of the business. Oregon Public Employees Retirement Fund grew its stake in shares of MAXIMUS by 6,329.9% in the 4th quarter. Oregon Public Employees Retirement Fund now owns 1,656,085 shares of the health services provider’s stock worth $25,000 after buying an additional 1,630,329 shares in the last quarter. Quantamental Technologies LLC purchased a new position in shares of MAXIMUS in the 4th quarter worth $38,000. Tributary Capital Management LLC purchased a new position in shares of MAXIMUS in the 4th quarter worth $52,000. Advisor Group Inc. grew its stake in shares of MAXIMUS by 47.3% in the 4th quarter. Advisor Group Inc. now owns 869 shares of the health services provider’s stock worth $56,000 after buying an additional 279 shares in the last quarter. Finally, Huntington National Bank grew its stake in shares of MAXIMUS by 262.5% in the 4th quarter. Huntington National Bank now owns 928 shares of the health services provider’s stock worth $60,000 after buying an additional 672 shares in the last quarter. 95.26% of the stock is owned by institutional investors and hedge funds.
MAXIMUS Company Profile
MAXIMUS, Inc provides business process services (BPS) to government health and human services programs worldwide. The company's Health Services segment offers various BPS, appeals, and assessments for state, provincial, and national government programs, including Medicaid, Children's Health Insurance Program, Affordable Care Act, Health Insurance British Columbia, Health Assessment Advisory Service contract, and Preadmission Screening and Resident Reviews.
Featured Article: The Role of a Fiduciary and Individual Investors
Receive News & Ratings for MAXIMUS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MAXIMUS and related companies with MarketBeat.com's FREE daily email newsletter.